| Name: | Dexamethasone sodium phosphate EP Impurity C |
| Catalogue No. | VE006237 |
| CAS No. | N/A |
| Molecular Formula | C22H30FO8P |
| Molecular Weight | 472.4 |
| Status | In-stock |
| IUPAC Name | ((1R,4aS,4bS,10aS,10bR,11S,12aS)-10b-fluoro-1,11-dihydroxy-3,10a,12a-trimethyl-2,8-dioxo-1,2,3,4,4a,4b,5,6,8,10a,10b,11,12,12a-tetradecahydrochrysen-1-yl)methyl dihydrogen phosphate |
| Synonyms | [D-Homo A Derivative Dexamethasone] / 16(17)a-Homodexamethasone sodium phosphate |
| Description | Dexamethasone sodium phosphate EP Impurity C or 16(17)a-Homodexamethasone sodium phosphate is a D-Homo derivative of the compound Dexamethasone which has a wide variety of uses in the medical domain. Dexamethasone has been evaluated for use in the treatment of acute exacerbations of multiple sclerosis, allergies, cerebral edema, inflammation, and shock. |
| References | 'Liguori, Angelo, et al. “D-Homoannulation of 17α,21-Dihydroxy-20-Keto Steroids (Corticosteroids).” Steroids, vol. 71, no. 13-14, Dec. 2006, pp. 1091–96,https://doi.org/10.1016/j.steroids.2006.10.001.Europe PMC. “Europe PMC.” Europepmc.org, 2016, europepmc.org/article/nbk/nbk482130.' |
![(16α)-21-[(Ethoxycarbonyl)oxy]-17-hydroxy-16-methylpregna-1,4,9(11)-triene-3,20-dione](/public/site/files/site_images/thumb_16alpha-21-ethoxycarbonyl-oxy-17-hydroxy-16-methylpregna-1-4-9-11-triene-3-20-dione47031.png)
